Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05448924
Other study ID # OBGY-202206.04
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2021
Est. completion date January 31, 2022

Study information

Verified date July 2022
Source Universitas Padjadjaran
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a case report of a 14-year old female with no menstruation history.


Description:

This is a case report of a 14-year-old with a chief complaint of inability to menstruate. Lab tests were done.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date January 31, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - A single female participant with amenorrhea Exclusion Criteria: - The study only included the above subject

Study Design


Intervention

Diagnostic Test:
Hormone panel tests
Patient was subjected to a battery of hormone tests, including FSH, LH, estrogen, progesterone and growth hormone

Locations

Country Name City State
Indonesia Department of Obstetrics and Gynecology, Universitas Padjadjaran Bandung West Java

Sponsors (1)

Lead Sponsor Collaborator
Universitas Padjadjaran

Country where clinical trial is conducted

Indonesia, 

References & Publications (1)

Crottaz B, Uské A, Reymond MJ, Rey F, Temler E, Germond M, Gomez F. Normogonadotropic primary amenorrhea in a growth hormone-deficient woman with ectopic posterior pituitary: gonadotropin pulsatility and follicle-stimulating hormone bioactivity. J Endocrinol Invest. 1996 Jan;19(1):48-53. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Growth hormone levels Growth hormone levels assessed by hormone panel 1 month after testing
See also
  Status Clinical Trial Phase
Recruiting NCT02243852 - Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) N/A
Completed NCT01440686 - Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers Phase 1
Completed NCT00990340 - Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method Phase 4
Completed NCT00235599 - The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children. N/A
Completed NCT00149708 - Consequence of Lifetime Isolated Growth Hormone Deficiency N/A
Completed NCT00459940 - The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients N/A
Completed NCT01157793 - A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood Phase 4
Completed NCT00004365 - Study of Pituitary Size and Function in Familial Dwarfism of Sindh N/A
Recruiting NCT00227253 - Chromosome 18 Clinical Research Center
Recruiting NCT04121780 - Growth Hormone Replacement Therapy for Retried Professional Football Players Phase 2
Completed NCT02934399 - Dynamic Hormone Diagnostics in Endocrine Disease
Completed NCT01090778 - Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I) Phase 2
Completed NCT01062529 - Peripheral Metabolic Effects of Somatostatin N/A
Completed NCT00965484 - Genotropin Study Assessing Use of Injection Pen Phase 3
Completed NCT00616278 - National Cooperative Growth Study in CKD N/A
Completed NCT02693522 - Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency Phase 3
Recruiting NCT02908958 - Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency Phase 4
Terminated NCT01243892 - A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device N/A
Withdrawn NCT00638287 - Inter-Assay Growth Hormone and IGF-I Variability N/A
Completed NCT00929799 - Growth Hormone and Glucose Metabolism Phase 4